Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

NCT07564232 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: LNK001

Sponsor

M.D. Anderson Cancer Center